Ashland Inc's Corporate Customers have recorded an advance in their cost of revenue by 5.04 % in the 3 quarter 2026 year on year, sequentially costs of revenue grew by 7.55 %. During the corresponding time, Ashland Inc recorded a revenue increase by 7.34 % year on year, sequentially revenue grew by 3.11 %. While revenue at the Ashland Inc 's corporate clients recorded rose by 7.42 % year on year, sequentially revenue grew by 9.41 %.
Ashland Inc's Customers have recorded an advance in their cost of revenue by 5.04 % in the 3 quarter 2026 year on year, sequentially costs of revenue grew by 7.55 %, for the same period Ashland Inc recorded revenue increase by 7.34 % year on year, sequentially revenue grew by 3.11 %.
Ashland Inc's Comment on Sales, Marketing and Customers
Ashland operates in various consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care, and pharmaceuticals. The company is organized into four reportable segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment serves manufacturers in pharmaceuticals, food, beverage, hospitals, and radiology. The Personal Care segment caters to formulators at large multinational branded consumer product companies as well as smaller independent boutique firms. Specialty Additives serves global paint manufacturers, electronics and automotive manufacturers, textile mills, the construction industry, and welders. The Intermediates segment produces chemical intermediates used in engineering polymers, polyurethanes, and specialty process solvents for various applications.
In a strategic move underscoring its commitment to innovation and globalization, Ashland Inc announced the expansion of its pharmaceutical plant in Brazil, significantly increasing production capacity for its Aquarius tablet coatings. This latest investment aligns with the company’s broader strategy to enhance its market presence and solidify its competitive position within the pharmaceutical sector.The Brazilian expansion is one of several key investments that Ashland has made recently, following previous enhancements to its facilities in Ireland and China. These initiatives reflect the company s determination to drive organic growth through an elevated output and refined product offerings, particularly i...
Ashland Inc. Divests Nutraceuticals Business to Focus on Core Operations and Strategic Growth In a significant strategic move, Ashland Inc. (NYSE: ASH) has officially completed the sale of its nutraceuticals business to an affiliate of Turnspire Capital Partners LLC. The decision, effective August 30, 2024, marks an important step for Ashland as it intensifies its focus on core operations and seeks to streamline its business portfolio to foster sustainable growth.The divestiture encompasses Ashland s custom formulation and contract manufacturing capabilities tailored for the nutrition market, which have been operational from its advanced production facilities located in New Jersey and Utah, as well as in Tam...
Ashland Inc., a global leader in additives and specialty ingredients, has recently unveiled significant executive organization changes aimed at strengthening its personal care and specialty additives businesses. With a focus on driving growth and enhancing customer experience, Ashland aims to leverage its expertise and innovation to stay ahead of market dynamics and meet evolving consumer demands.Restructuring for a Sustainable Future:In response to a challenging economic landscape, Ashland Inc. has adapted its corporate structure to bolster its personal care and specialty additives divisions. This strategic move enables the company to capitalize on market opportunities while improving operational efficiency...
Ashland Inc’s Comment on Sales, Marketing and Customers
Ashland operates in various consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care, and pharmaceuticals. The company is organized into four reportable segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment serves manufacturers in pharmaceuticals, food, beverage, hospitals, and radiology. The Personal Care segment caters to formulators at large multinational branded consumer product companies as well as smaller independent boutique firms. Specialty Additives serves global paint manufacturers, electronics and automotive manufacturers, textile mills, the construction industry, and welders. The Intermediates segment produces chemical intermediates used in engineering polymers, polyurethanes, and specialty process solvents for various applications.
Sources:
Ashland Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Ashland Inc’s corporate clients.
For your research, we’ve provided 9 tables on Ashland Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
13.68 %
14.31 % 